Update on gene therapy clinical trial at Abeona and Stanford University

Abeona Therapeutics announces the publication of positive long-term data from Phase 1/2a clinical trial evaluating EB-101 gene therapy for recessive dystrophic Epidermolysis bullosa.

See publication here.